Trials / Sponsors / AnGes, Inc.
AnGes, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) COVID-19 Lower Respiratory Infection | Phase 1 / Phase 2 | 2021-07-29 |
| Completed | Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) COVID-19 | Phase 2 / Phase 3 | 2020-11-23 |
| Completed | Study of COVID-19 DNA Vaccine (AG0302-COVID19) COVID-19 | Phase 1 / Phase 2 | 2020-08-31 |
| Completed | Study of COVID-19 DNA Vaccine (AG0301-COVID19) COVID-19 | Phase 1 / Phase 2 | 2020-06-29 |
| Completed | AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain Degenerative Disc Disease | Phase 1 | 2018-02-26 |